SBRT 2016

Recent randomized studies in Radation Oncology

Study characteristic published in 2015

Median age at diagnosis (SEER)

Tumor entity Study question

Median age

Maximum age

54 years

75 years

61 years

Breast

RT of mammaria interna

54 years

84 years

61 years

Breast

RT of mammaria interna

Dose escalation Cetuximab Adjuvant CT after neoadjuvent RCHT

64 years

83 years

70 years

NSCLC

62 years

68 years

68 years

Rectal

72 years

85 years

66 years

Prostate

Duration AHT

Hypofractionation of RT

71 years

75 years

66 years

Prostate

 Lack of evidence covering elderly patients

ESTRO SBRT COURSE 2016 - Matthias Guckenberger

9

/